Skip to main content

Health: Contaminated Blood Products

Volume 712: debated on Monday 20 July 2009

Question

Asked by

To ask Her Majesty's Government further to the Written Answer by Lord Darzi of Denham on 1 July (WA 55), whether officials at the Department of Health were aware of the risk of vCJD that applied to infected beneficiaries supported by the Macfarlane Trust when they held their discussion with the Association of British Insurers. [HL5032]

The department was aware of the risk of variant Creutzfeldt-Jakob disease (vCJD) that applied to affected beneficiaries supported by the Macfarlane Trust when we were in discussion with the Association of British Insurers (ABI) following Lord Archer’s report into National Health Service Supplied contaminated blood and blood products. However, as identified in my Written Answer on 1 July (WA 55), the CJD Incidents Panel has separately discussed with the ABI the issue of patients who might be at risk of having been infected with vCJD after receiving contaminated blood and blood products.

Asked by

To ask Her Majesty's Government further to the Written Answer by Lord Darzi of Denham on 29 June (WA 15), whether Department of Health officials have been advised by the Macfarlane Trust of the number of applications so far for life insurance that have been made by infected beneficiaries supported by the Macfarlane Trust. [HL5033]

To ask Her Majesty's Government further to the Written Answer by Lord Darzi of Denham on 29 June (WA 15), whether Department of Health officials have been advised by the Macfarlane Trust whether the Trust would share information in respect of how many applications for life insurance have been made by infected beneficiaries supported by the Trust; and, if so, what is their assessment of that information. [HL5034]

Department of Health officials have not been advised by the Macfarlane Trust of the number of life insurance applications made by its beneficiaries and have not been advised by the trust about possible sharing of such information.